Coventry Shifting Medicare PBM Duties To Medco From CVS Caremark
Executive Summary
Medco credits its pharmacist-based therapeutic research center program with helping to attract new Medicare Part D business from Coventry Health Care
You may also be interested in...
Universal American, CVS/Caremark End Part D Alliance With Membership Split
CVS/Caremark will add Medicare members to its SilverScript stand-alone prescription drug plans in 2009 under an "amicable split" with Part D partner Universal American, announced Feb. 13
Warfarin Dosing Issues Emerge In Early Results From Medco/Mayo Research
Nearly three-fourths of early patient participants in a warfarin research project appear to need non-standard dosing of the drug based on genetic screening, Medco reported during its analyst day presentation Nov. 16
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.